Normal skin is permeable to low molecular hydrophobic substances, including allergenic chemicals. Whereas such foreign matter appears to enter the skin naturally, it rarely induces contact hypersensitivity. This suggests that immunological tolerance would be the normal state of affairs. In search of a suitable model, we painted picryl chloride or oxazolone once or repeatedly on normal skin of BALB/c or C57B1/6 mice and found subsensitizing doses to be tolerogenic. The most effective doses in inducing tolerance were doses between those at the point of inflection from no responses to threshold sensitivity. But even doses three orders of magnitude lower than these suppressed subsequent sensitization if applied repeatedly. C57B1/6 mice (low responders) were consistently easier to make tolerant than BALB/c mice (high responders). The tolerant state established by a single painting was found to be fully developed at 48 h after initiation and long-lasting (> 14 d). It could be adoptively transferred by intravenous injection of total spleen cells (SC), lymph node cells (LNC), or purified T cells and shown to be hapten specific. Pretreatment with cyclophosphamide (Cy) prevented tolerization. The T cells capable of transferring suppressive activity were found to be generated irrespective of the dose applied. On day 2 after painting, tolerance could be transferred with LNC from both tolerant and sensitized animals. On day 5, however, only cells from tolerant donors transferred tolerance. But by action of Cy, suppression was shown to be part of every sensitization, although masked. Production ofhapten-specific antibodies was suppressed as well. Through depletion by monoclonal antibody in vitro the T suppressor cells were shown to belong to the murine CD8 + subset (Lyt2+). Upon restimulation in vitro by haptenized and irradiated normal SC, LNC from tolerant donors produced predominantly interleukin (IL)-4, IL-5, and IL-10. In contrast, LNC from sensitized donors produced preferentially IL-2 and interferon-"/. Thus we demonstrate that painting subsensitizing doses of contact sensitizers on normal murine skin generates CD8 + Th2-1ike cells that give rise to hapten-specific tolerance. The model may have broader significance and apply to other species, including humans.
A nimal models of contact hypersensitivity (CHS) t to haptenic molecules (1) have contributed greatly to understanding the mechanisms that govern allergic contact dermatitis. This major skin disease causes considerable distress to affected patients and, in the form of occupational contact dermatitis, immense costs for society (2) . Even now, the allergen-specific hypersensitive state, once established, cannot be reversed clinically, making it necessary to avoid forever the causative agent.
~Abbreviations used in this paper: CHS, contact hypersensitivity; Cy, cyclophosphamide; LNC, lymph node cells; Ox, oxazolone; PC1, picryl chloride; SC, spleen cells; TNBS, 2,4,6-trinitrobenzenesulfonic acid.
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However, it is known that entrance through the skin of haptenic molecules generates not only T lymphocytes effecting inflammatory symptoms in sensitized skin but induces as well T cells that exert anti-inflanunatory effects (3) . These latter cells generally have been termed suppressor cells (4) , and upon selective stimulation they mediate a state of hapten-specific tolerance (5) (6) (7) (8) . They were shown to negatively regulate the immune response in an unsuspected complex manner with several sets of T cells involved, each having characteristic surface markers and producing specific factors (9) . It was proposed that in all murine systems, T cell suppression proceeds by a single major pathway involving the sequential interactions of three T cell subsets that have been termed Ts~, Ts2, and Ts 3 (10) .
More recently, the T suppressor cascade as outlined above has been replaced by a simpler model of suppression (11) based on the finding that not only CD4 + but also CD8 § T lymphocytes separate on appropriate stimulation into functional subsets termed type 1 and type 2. These subsets are defined by the pattern of lymphokines produced, with IL-2 and IFN-~/being the predominant cytokines of the type 1 pattern and IL-4, IL-5, and IL-10 those of the type 2 pattern. The concept has been worked out in CD4 + cells first (12, 13) , but there is recent evidence that it applies as well to the CD8 + phenotype (14) . Most interesting in this respect is the finding that naive CD8 § T cells can be induced in vitro to secrete the helper cytokine IL-4 (15) . Moreover, CD8 § T cells were shown in the presence of IL-4 to switch to B cell help and the production of Th2 cytokines, but to lose cytotoxic activity (16) . Although such CD8 + Th2-like cells also have been shown to exist in mice and humans (17) (18) (19) (20) (21) (22) it is still considered a "challenging task" to demonstrate that antigen-specific CD8 + Th2-like cells can be derived directly in vivo (23) .
Immunological tolerance is known to be the classical field of activity for suppressor T cells. We hypothesized that CD8 + Th2-like cells could play a functional role there. To test this hypothesis, we induced tolerance in mice by painting subsensitizing doses of allergenic chemicals on normal skin. We chose this particular model for two reasons. First, the induction of tolerance by dilute amounts of foreign matter passing through the skin could have pathophysiologic significance, as it might represent a fundamental mechanism dealing with the handling of non-self that enters the body in small amounts by way of the skin. Second, the induction of tolerance by painting nonimmunogenic doses of chemical allergen on normal skin has already been observed fortuitously by Chase (24) as early as 1943. Later on it was shown that low doses of contact sensitizers applied epicutaneously indeed effect hapten-specific tolerance (25) (26) (27) . The original observation was subsequently confirmed (28) , also by chance, but in mice efficacy in tolerization of topical exposure to low doses still requires rigorous proof.
We found that low dose tolerance to chemical allergens was clearly dose dependent, hapten specific, and long-lasting. It could be adoptively transferred by cyclophosphamide (Cy)-sensitive T cells that also extended their suppressive activity to antibody production. They were found to belong solely to the routine CD8 + T cell subset. Upon restimulation by hapten in vitro, these cells produced preferentially helper cytokines, that is, IL-4, IL-5, and IL-10, whereas lymph node cells (LNC) from sensitized mice produced predominantly IL-2 and IFN-~/. Thus, we demonstrate that low zone tolerance to contact allergens is mediated by CD8 + Th2-like cells.
Materials and Methods
Animals. BALB/c mice and C57B1/6 mice were purchased from Charles River (Sulzfeld, Germany). Animals were maintained in a temperature-and light-controlled environment with free access to food and water. During experiments, arrimals of both sexes at 8-12 wk of age were housed singly in transparent Makrolan cages. Experimental groups consisted of five or more animals matched for age and sex. All mice in each experiment, including both normal and positively sensitized controls, were randomized in advance with respect to cage position in the room.
Chemicals. Picryl chloride (PC1; 2,4,6-trinitro-l-chlorobenzene), oxazolone (Ox; 4-ethoxy-methylene-2-phenyl-oxazolone), TNBS (2,4,6-trinitrobenzenesulfonic acid), and Cy monohydrate were all purchased from Sigma (Deisenhofen, Germany).
Experimental Sensitization and Tolerization. The right ear was used for sensitization and the left ear was used for challenge. When more than one application for sensitization was desired, allergens were applied on clipped areas of abdomen or dorsum as required. Both allergens were dissolved in olive oil/acetone (1 : 5); solutions were prepared immediately before using. Culture Media. tLPMI-1640 was supplemented with 2 mM glutamine, 100 U/ml penicillin, 100 p~g/ml streptomycin, 10% heat-inactivated FCS (all from Gibco, Eggenstein, Germany), 5 • 10 -s M 2-ME, and 1 p~g/ml indomethacin (both from Sigma).
Preparation of LNC, Spleen Cells, and Purified T Cells. 5 d after sensitization or 2 d after the last painting of a tolerizing dose, respectively, mice were killed by ether euthanasia and spleens or lymph nodes were taken. LNC were obtained either from auricular, inguinal, or mesenteric lymph nodes. Single cell suspensions of LNC or spleen cells (SC) were prepared under aseptic conditions by mechanical disaggregation and passed through a sterile nylon gauze. Cells were washed three times and resuspended in RPMI-1640 complete. Viability was noted to be >95%, as determined by trypan blue exclusion. Purified T cells were prepared using the method of Julius et al. (29) . Briefly, LNC (10V/ml) were incubated in a nylon wool column for 1 h at 37~ After two washings with medium, T cells were pelleted by centrifugation and viability was determined by trypan blue exclusion. Lymphokine ELISAs. LNC (2 X 10 s cells/well) were incubated with 105 hapten-modified and irradiated (2,500 rad) SC using 96-well round-bottomed microtest plates (Greiner, Frickenhausen, Germany). After 72 h of culture in a humidified atmosphere of 5% CO2 at 37~ supernatants were harvested, spun at 750 g for 15 rain to eliminate dead debris, and frozen at -80~ ELISAs for IL-2, IL-4, IL-10, and IFN-~/were performed using sandwich ELISA kits purchased from Genzyme (Ismaning, Germany). All protocols were completed according to the manufacturer's instructions. IL-5 was quantified in a two-side sandwich ELISA as described previously (30) . Briefly, maxisorb plates (Nunc, Wiesbaden, Germany) were coated with 50 ~1 of 2 ~g/ml rat antimouse IL-5 antibody (clone TRFK5; Dianova, Hamburg, Germany) and incubated overnight at 4~ Subsequently, wells were blocked by adding 200 ILl 10% FCS in PBS for 2 h at room temperature. Samples and standards (recombinant murine IL-5; Biermann, Bad Nauheim, Germany) were diluted in R.PMI-1640 complete and incubated for 4 h at room temperature. After washing, each well received 100 I~1 of 1 Ixg/ml biotinylated rat anti-mouse IL-5 (clone TR.KF4, Dianova). Plates were incubated for 45 min at room temperature followed by three washings. Streptavidinhorseradish peroxidase was added at a concentration of 1 ~g/ml (100 ~1) and incubated at room temperature for 30 rain. Plates were subsequently washed 10 times, and 100 b~l substrate (ABTS, 2,2-azino-di-3-ethylbenzthiazoline sulfonate; Boehringer, Mannheim, Germany) at a concentration of I mg/ml in 44 mM NazHPO, 28 mM citric acid, and 0.003% H20 z was added. The colored product was measured at a wavelength of 405 nm. Samples were assayed in duplicate and differences between replicate wells were uniformly <5% for IL-2, IL-5, and IFN-% and <10% for IL-4 and IL-10. The sensitivities for these assays are IL-2 <10 pg/ml, IL-4 <1 pg/ml, IL-5 <15 Izg/ml, IL-10 <1 pg/ml, and IFN-~/ < 1 pg/rnl.
ELISA for Anti-Ox and Anti-PCl Antibodies (According to (31)).
Hapten protein conjugates were prepared for use in ELISA. Ox (60 mg in 0.5 ml methoxyethanol) was added slowly to 10 ml of a 25 mg/ml solution of BSA in 0.5 sodium bicarbonate buffer. The mixture was stirred for 3 h at room temperature and the pH maintained at 8 by addition of 1 M sodium hydroxide. Protein was desalted by Sephadex G-25 column chromatography (Pharmacia, Freiburg, Germany), dialyzed against water, lyophilized, and stored at -20~ For the detection of antibodies to PC1, a second conjugate was similarly prepared substituting PC1 for Ox. The wells of plastic microtiter plates (Nunc) were coated with 100 Izl (10 Ixg) ofhapten protein conjugate in PBS. After incubation for 18 h at 4~ plates were washed three times with PBS containing 0.5% Tween 20. Subsequently, serum samples were placed on the plates using serial logarithmic dilutions and maintained for 2 h at 4~ This was followed by the addition of goat anti-mouse IgG, IgG1, IgG2a, IgG2b, and IgG3 conjugated with peroxidase at a concentration of 1 I~g/ml (Camon, Wiesbaden, Germany); bound antibodies were detected by the addition of ABTS. Antibody titers are expressed as mean OD 405 nm_ SEM.
Statistics. Statistical significance of differences between experimental groups was evaluated using the Wilcoxon-Mann-Whitney two sample test. Differences of.p <0.01 were considered significant.
Results and Discussion
The Murine Model. An in vivo model was required that, besides easy handling, would permit ready detection of doserelated differences in response to experimental sensitization. This was achieved by painting various doses ofhapten once onto one ear, a site whose lymphatic drainage is clearly defined. When more than one application was needed, abdominal or dorsal skin sites or both were treated in addition with hapten. The other ear was reserved for determining the attained sensitivity in a contact test.
A conspicuous dose dependency was found in the animals' reactivity to both PC1 and Ox. With PC1 as sensitizer, single doses in 15 Ixl olive oil/acetone (1:5) ranging from 1.8 X 10 -12 to 3 X 10 -5 tool were used. A somewhat narrower dose range of Ox was examined, extending from 3.5 X 10 -11 to 4 X 10 -6 mol. Dose-response curves were established first in BALB/c mice known to be an inbred strain of high responders, and subsequently in C57B1/6 mice, an inbred strain of low responders (32, 33) . Fig. 1 , A and B shows that very low doses did not cause noticeable responses upon contact testing 5 d later. Increasing the dosage stepwise gave rise to inflammatory reactions on the challenged ear ranging from threshold sensitivity caused by 4.5 ~g PCI or 7.5 I~g Ox to full CHS secured by 450 I~g PC1 or 750 I~g Ox. Increasing the dosage further did not intensify the ear swelling, indicating that a plateau of high responsiveness had been reached. Degrees of CHS inducible in BALB/c mice were consistently higher than those in C57B1/6 mice but, in principle, dose dependency of responses to the two sensitizers was essentially the same. Thus, under the conditions elaborated, two chemically unrelated allergens exerted sensitizing capacity within a dose range of two orders of magnitude, covering therein a spectrum from minimal to optimal sensitization.
The Tolerogenic Effect of Subsensitizing Doses. Doses that had been found to be too low to sensitize BALB/c mice and C57B1/6 mice adequately, both of PC1 and Ox, were assumed to be nonetheless high enough to cause tolerance. Proof of efficacy in this respect came from experiments in which those animals that had not sufficiently responded to the first treatment were subjected to effectual sensitization on second attempt. They were found to attain significantly lower sensitivities than animals pretreated solely with solvent (Fig. 2) . The initial stimulus from the low dose application was followed directly 7 d later by intentional sensitization, avoiding a contact testing in between lest there be any influence, in whatever direction, upon the ongoing process.
The presence of tolerance must be proved through a subsequent attempt to sensitize. This is usually performed rigidly to be most convincing. However, it is possible for too strong a sensitizing regimen to override a tolerogenic stimulus and thus leave a tolerogenic component unrecognized. In the model presented here, sensitization was performed by a single painting of a dose of allergen found to be adequate to secure full sensitivity but not to exceed the dose required to avoid flooding the organism with the allergenic hapten.
Evidently, tolerization is precisely as dose dependent as is sensitization, although at a dose range three orders of magnitude lower. The most effective tolerizing doses were 4.5 txg PC1 and 7.5 I.tg Ox, as seen in Fig. 1, A Ox, were essentially ineffectual in establishing tolerance by a single application. However, repeated application of low doses enhanced tolerance considerably. We tried several regimens, administering equal or unequal doses at various intervals, on one or on different sites; we finally determined the most effective treatment to be several applications of equal doses applied every other day on different sites. Consequently, three applications of a dose whose tolerogenic effect was insignificant when applied just once, did actually downregulate subsequent sensitization significantly when duly spaced out. Six applications (not shown) rather than three enhanced tolerance further and ten applications were still more effective (Fig. 3) . Tolerance reached higher levels in C57B1/6 mice (up to 100%) than in BALB/c mice (up to 80%), owing to genetic factors (32, 33) . Kinetics. The kinetics underlying the development of tolerance was examined by carrying out the subsequent active sensitization after different time intervals. It was found that up to 24 h after application ofa tolerizing dose, no downregulating effect was demonstrable. At 36 h, downregulation was apparent but not yet at a significant level. At 48 h after the tolerizing application, however, the suppressive effect was statistically significant with no further increase for up to 14 d (Table 1) . When the time interval between a single tolerizing application and subsequent sensitization was prolonged to 21 d, tolerance had meanwhile faded.
However, four tolerizing paintings on the right ear at weekly intervals and subsequent sensitization after another week extended the tolerant state to 5 wk (not shown). By cellular transfer technique as a tool of investigation it was confirmed that cells derived from regional (auricular) lymph nodes taken at 48 h after the tolerizing application exerted suppressive activity upon subsequent sensitization of the recipients with no further increase of efficacy later (data not shown). These results demonstrate that tolerance is established more rapidly than CHS. When sensitization was tested at 48 h, the response was practically zero.
Transfer of Tolerance. Adoptive transfer of cells from tolerant BALB/c or C57B1/6 mice into naive recipients was performed by intravenous injection of SC, LNC, or purified T cells from regional nodes ( The tolerogenic dose of 7. after transfer had been double sensitized, exhibited upon contact testing significantly downregnlated responses to the allergen in question but attained full CHS to the unrelated chemical. Thus, the tolerant state induced by low doses of allergen applied onto normal skin was long-lasting (> 14 d) and mediated by hapten-specific suppressor cells. Moreover, adoptive transfer experiments revealed that not only were cells derived from regional nodes effective in downregulating subsequent sensitization but also cells derived from lymph nodes draining distant skin sites and even distant nmcosal areas (Fig. 4) . However, the degree of transfer from the different sources was not equal, being highest in cells from regional nodes, somewhat lower in cells from inguinal nodes, and lowest in cells from mesenteric nodes, irrespective of whether the transferred cells had been harvested on day 2 or 5 after tolerization.
The same technique also showed that the application of sensitizing doses induced generation of suppressor cells, which however, were detectable only at 48 h after sensitization. Of viable cells, 10 v were as effective in downregulating subsequent sensitization as 10-fold as many cells (Fig.  5) . In contrast, transfer of cells harvested on day 5 after sensitization showed no suppressive activity (not shown).
Sensitivity to Cy. The suppressor cells that were found to be present surprisingly early and that were widely distributed among peripheral lymphatic organs, were tested for sensitivity to Cy. This drug is known to act on B cells and a population of shortqived, rapidly proliferating suppressor T cells (34, 35) . Both BALB/c and C57B1/6 mice were treated with Cy (200 mg/kg, i.p.) 2 d before epicutaneous application of either tolerizing or sensitizing doses or only the solvent. Compared with animals that had not been pretreated with Cy, the tolerizing effect of low allergen doses was completely annihilated (Fig. 6) . Moreover, the degree of CHS attained upon subsequent sensitization of all experimental groups was found to be considerably enhanced as compared to control animals left untreated with Cy. Obviously, through elimination of precursor cells before experimental tolerization and sensitization, the generation of hapten-specific suppressor cells was prevented in the Cytreated groups and thereby, the induction of tolerance precluded, whereas sensitization was improved. In a further experiment along this line, animals of both strains were treated with Cy and sensitized to Ox 2 d later. Upon challenge, the usual test dose (30 p,g Ox) was compared with two log10 doses farther down (Table 3) . Upon contact testing it became apparent that the Cy-treated animals responded to a test dose that was 10-fold below the dose to which untreated animals used to respond. Thus, removing suppressor cells from the normal pool of haptenspecific effector cells by Cy treatment revealed suppression to be a usual constituent of sensitization as a whole.
Suppression of Antibody Production. To see whether suppressor cell activity in our model would also involve suppression of antihapten antibody production, 10 C57BI/6 mice were rendered tolerant to Ox by painting 7.5 Ixg Ox 10 times every other day on different abdominal and dorsal skin sites. Similarly, 10 control animals were painted solely with the solvent. 2 d after the last paintings, both groups were given a single sensitizing painting of 750 Izg Ox on the right ear and ear challenged 5 d later on the left ear. As expected, mice pretreated with 10 subsensitizing doses were completely tolerant; the positive control group was well sensitized (data not shown). Another group of mice was sensitized to PC1 instead for "negative" control. Half of o the animals were bled on day 12 after the sensitizing painting, the other half on day 19. Fig. 7 shows that in tolerant mice, hapten-specific antibodies were significantly diminished as compared to those in sensitized mice. The titers measured in sera of tolerant animals were at the same low level as those in negative controls sensitized to PC1. This was also found in the subclasses IgG1 (Th2 response) and IgG2a (Thl response), as well as in the subclasses IgG2b and IgG3 (not shown). Antibody production measured on day 12 was not significantly different from that on day 19. Similar results were obtained when BALB/c mice were used, although suppression was not as complete. With PC1 as tolerizing or sensitizing agent, antibody titers measured in both strains were generally lower.
Depletion of T Cell Phenotypes.
To further characterize the suppressor cells, lymphoid cells from auricular lymph nodes draining the site of application ofa tolerizing dose were depleted in vitro by mAb to either L3T4 or Lyt2 antigens. The antibody-coupled cells were removed by magnetobeads coupled with sheep anti-rat IgG. The residual cells were adoptively transferred into naive animals with 107 cells each and compared to adoptive transfer of 107 cells of the total cell pool. After sensitization within 60 rain after transfer and elicitation 5 d later, readings of ear swelling revealed that tolerance was transferred by the fraction depleted of L3T4 cells, whereas the fraction depleted of Lyt2 cells did not downregnlate subsequent sensitization (Fig. 8) . With PCI as tolerizing agent, results were essentially the Adoptive transfer of in vitro-depleted LNC derived from tolerant donors. 70 BALB/c mice were tolerized by six consecutive paintings of 7.5 p~g Ox every other day on different sites, with the last two apphcations painted simultaneously on both ears. After 2 d, the animals were killed and the auricular lymph nodes of both sides taken. Cells derived from these nodes were depleted in vitro by mAbs to either L3T4 or Lyt2 antigens, and the antibody-coupled cells were removed by magnetobeads coupled with sheep anti-rat IgG. Equal numbers of viable cells (107) of the nondepleted original cell pool and of both fractions were adoptively transferred into panels of naive BALB/c mice (seven each).
The recipients (hatched bars), and also tolerized and solvent-treated controls (solid bars), were sensitized within 60 rain after transfer by a single painting of 750 ~g Ox on the right ear and challenged 5 d later on the left ear. With C57B1/6 mice treated similarly with PC1, results were comparable (not shown).
is characteristic for efferent suppressors (9) . They are equivalent to the third subset of the murine suppressor T cell circuit, termed Ts 3 cell, that is highly sensitive to Cy, antigen specific, and expresses the Lyt2 § phenotype (9) . The Ts 3 type was originally described by Sy et al. (36) and designated Ts-aux (auxiliary suppressor cells) as being essential for suppression of CHS.
Patterns of Cytokine Production after In Vitro Activation.
In light of the present knowledge of immunosuppression by T cells (11) it was mandatory to determine whether LNC from tolerant mice would, upon appropriate stimulation, produce a different pattern of cytokine activity than LNC from sensitized mice. Regional lymph nodes were taken from tolerized, sensitized, and solvent-treated mice of both strains, and disaggregated. LNC were then incubated with SC that had been haptenized in vitro with TNBS and subsequently irradiated. After coculturing the cells for 3 d, the supernatants were tested for Th2 cytokines as well as Thl cytokines. It was found ( Table 4 ) that LNC derived from tolerant mice produced predominantly IL-4, IL-5, and IL-10, but no detectable IL-2 and little IFN-',/. Conversely, LNC from sensitized mice secreted preferentially IL-2 and IFN-y, but little IL-4, IL-5, and IL-10. Moreover, BALB/c mice (high responders) produced significantly more IL-2 than C57B1/6 mice (low responders) but less IL-4, IL-5, and IL-10.
We did not investigate the entire spectrum of cytokine production but rather concentrated on the critical cytokines that characterize the two patterns (37) . Originally, they were discovered by Mosmann and co-workers (12, 13) in a panel of murine helper T cell clones, that is, in CD4 + T cells. Some years later it was shown that alloreactive murine CD8 § T cell clones also produce the Thl pattern: they secrete IFN-y and lymphotoxin similar to Thl clones but IL-2 at significantly lower levels (14) . However, synthesis oflL-4 and IL-5 could not be detected. But eventually it was reported that CD8 + T cells can be induced to produce IL-4 as well (15) . When such cells were primed in vitro with immobilized antibodies to CD3 (8 chain of the TCR complex) in the presence oflL-2 and IL-4 they were as active in producing IL-4 as similarly primed CD4 + T cells. Thus, naive CD8 + T cells also differentiate upon appropriate stimulation into functional subsets that act like the two helper T cell subsets.
The sole variable in our model is the dose of hapten applied. Low doses initiate an immune response that is entirely different from that initiated by high doses, suggesting compartmentalization of functional subsets of T cells. We have found that LNC ceils from mice tolerant to contact sensitizers produced preferentially type 2 cytokines, whereas, LNC from sensitized mice produced predominantly type 1 cytokines. It must be emphasized that the LNC derived from our tolerant mice are not exclusively composed of CD8 + suppressor cells, just as LNC from sensitized mice do not solely contain CD4 + Thl cells (38) but include regularly suppressor cells, as shown by pretreating mice with Cy (Fig. 6 ). Nonetheless, a switch in cytokine production was obvious from a typical Thl response in sensitized mice to a Th2 response in tolerant mice. However, on the B cell level such a switch was not detectable. Either the method used was not sensitive enough or antibody production to these particular antigens was indeed completely suppressed, as was delayed hypersensitivity. The differences in producing the respective cytokines among the two strains (Table  4) appear to reflect their different genetic backgrounds (32) and explain, in part, their diverse responses to tolerization and sensitization. This is the first demonstration, to our knowledge, that suppressor cells generated in low dose tolerance to contact allergens are CD8 + Th2-1ike T cells. Through their production and secretion of Th2 cytokines, they exert anti-inflammatory effects that counteract subsequent attempts to sensitize.
Obviously, CD8 + Th2-1ike ceils have a different significance in tolerance to contact allergens than in infectious disease. Unresponsiveness to intracellular pathogens such as Mycobacterium leprae results in decreased resistance. In fact, Panels (six each) of both mouse strains were painted with solvent solely or either tolerized (six consecutive paintings of 4.5 b~g PCI every other day on different sites, with the last two applications painted simultaneously on both ears) or sensitized (single painting of 450 ~g PCI on one ear). 2 d after the last tolerizing application or 5 d after the sensitizing painting, respectively, mice were killed and their regional lymph nodes taken. After mechanical disaggregation, LNC from these various groups were separately cocultured for 3 d with TNBS-haptenized and irradiated normal SC. Supernatants were subsequently harvested and kept frozen for further use. Denoted cytokines were measured in samples of the supernatants by sandwich ELISAs. Values presented are mean • SEM of two separate experiments.
human CD8 + Th2-like cells were found to be present in skin lesions of the susceptible lepromatous form of leprosy that contain large numbers ofbaciUi (17) . In contrast, CD4 + Thl cells secrete IFN-~/preferentially and are the predominant cell type present in the resistant tuberculoid lesions of leprosy that contain few bacilli. In a mouse model using transgenic mice, it was shown more recently that an IL-4-dependent switch to IL-5 production in virus-specific CD8 + T cells delayed viral clearance from the murine host (21) . Low zone tolerance to contact allergens has certain features in common with inhalation and oral tolerance to nonreplicating antigens. In an experimental model developed for eliciting immune responses to low doses of inhaled OVA repeated exposures to this antigen rendered rats tolerant to subsequent parental immunization with OVA. This tolerant state was selective for the IgE antibody isotype and could be transferred adoptively with CD8 + T cells. However, the cells mediating this particular state of tolerance were found to secrete upon in vitro activation high levels of IL-2 and IFN-% that is, type 1 cytokines (39).
Different immunologic mechanisms appear to underly oral tolerance depending on dosage and frequency of feeding (19) . Low dose antigen feeding generated active suppression by T cells producing IL-4, IL-10, and TGF-~3. In contrast, high dose feeding enhanced the secretion of both Th2 and Thl cytokines. Moreover, clonal energy was found to be involved in high dose tolerance, and in Peyer's patches antigen-reactive Thl and Th2 cells were deleted by activation-induced apoptosis (40) .
We are inclined to believe that tolerance to potential contact sensitizers might have pathophysiological importance. It could represent a fundamental mechanism dealing with small amounts of a foreign substance penetrating the skin. Such a mechanism would prevent an inflammatory response that otherwise would be inevitable unless a massive amount of that substance were to exceed the allowance. Tolerance would then be broken and contact dermatitis would result. "Contact tolerance" seems to apply to this type of peripheral hyporesponsiveness and we take the risk of proposing the term.
